Amgen has reported encouraging mid-stage results for its olpasiran candidate for reducing lipoprotein(a) – a risk factor for atherosclerotic cardiovascular disease – and now plans to move ahead ...
Phase transitions and critical phenomena are the changes of a system from one regime or state to another exhibiting very different properties, and the unusual effects that occur on the boundary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback